ETIB Clinical Research Core

ETIB 临床研究核心

• 批准号: 10926676
• 负责人: Ronald Gress
• 金额: $ 4.33万
• 依托单位: DIVISION OF BASIC SCIENCES - NCI
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10926676
• 关键词: Caring; Clinical; Clinical Research; Clinical Trials Design; Collection; Data Analyses; Data Collection; Education; Goals; Hematopoietic Stem Cell Transplantation; Immunology; Individual; Infrastructure; Malignant Neoplasms; Patient Care; Patient Recruitments; Policies; Translational Research; Transplant Recipients; Transplantation; Work; career development; clinical care; design; member; programs; transplantation therapy

The Experimental Transplantation and Immunology Branch (ETIB) clinical transplantation program has as goals the cure of cancer through hematopoietic stem cell transplant therapies, conducting outstanding translational research, and providing the highest level of excellence in clinical care. The ETIB Clinical Core provides interactions, activities and support across the branch. It represents a collection of individuals each with particular expertise in clinical transplantation and clinical research. While the section functions as a coordinated effort, it is also designed for individual career development and professional advancement for members. Specific aims include developing a supportive infrastructure for the conduct of clinical transplantation trials, establishing consistent clinical policies and practices in the care of transplantation patients in order to achieve excellence in clinical care, and providing and promoting educational opportunities in hematopoietic stem cell transplantation. The work of the ETIB clinical research core concluded in FY23.

实验移植和免疫学分支（ETIB）临床移植计划是通过造血干细胞移植疗法治愈癌症的目标，进行了出色的转化研究，并提供了临床护理的最高水平。 ETIB临床核心提供整个分支机构的相互作用，活动和支持。它代表了每个人的集合，每个人在临床移植和临床研究方面具有特殊的专业知识。尽管该部分是协调的努力，但它还为成员的个人职业发展和专业发展而设计。具体目的包括为进行临床移植试验的进行开发支持基础设施，建立一致的临床政策和实践，以在移植患者的护理中，以实现临床护理方面的卓越，并为血肿干细胞移植提供和促进教育机会。 ETIB临床研究核心的工作在财年中得出结论。